Amgen
PublicTrace currently links 391 federal records across 12 source groups to this company, spanning 2013-07-03 through 2026-10-25. The largest record category is securities disclosures. Inspect sample evidence and follow the original agency links before using a record in a consequential decision.
Selected public evidence
records · 2013-07-03 to 2025-03-26
OSHA · DOLWorkplace safety & labor2records · 2024-04-09 to 2024-08-29
EPAEnvironmental record2records · 2024-01-01 to 2024-01-01
LDAFederal lobbying46filings · 2016-01-20 to 2026-01-20
SECSecurities disclosures178filings · 2017-02-14 to 2026-10-25
4 additional source groups are available in the complete history.
Sample federal records
Showing up to five records from selected enforcement, operating-history, lobbying, disclosure, and restricted-party categories. This is not an exhaustive search. Category totals count linked records, not actions against this company. Roles are shown separately; unknown does not mean wrongdoing or clearance.
Federal enforcement-related records
Showing 5 of 9
-
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. FDA · Enforcement-related record Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. FDA · Enforcement-related record Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Amgen Inc. and Horizon Therapeutics plc, FTC v. FTC · Enforcement-related record Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Defective container: loose crimp defect, potential loss of container integrity. FDA · Enforcement-related record Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Celadon Group, Inc. Enters into Corporate Resolution for Securities Fraud and Agrees to Pay $42.2 Million in Restitution (dpa, plea) DOJ · Enforcement-related record Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View specific source record ↗
Workplace safety & labor
Showing 2 of 2
-
OSHA Other violation (citation 01001) — penalty $3,000.00 OSHA · Violation Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed through the establishment record; verify the named party.View source (document specificity unverified) ↗
-
OSHA inspection of AMGEN INC. (activity 347399990) OSHA · Inspection Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed through the establishment record; verify the named party.View source (document specificity unverified) ↗
Environmental record
Showing 2 of 2
-
TRI report for AMGEN MANUFACTURING LTD LLC (2024)View source (document specificity unverified) ↗
Toxics release filing — facility AMGEN MANUFACTURING LTD LLC
EPA · Release Report Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed through PublicTrace entity resolution; verify the named party. -
TRI report for IMMUNEX RHODE ISLAND CORP A SUBSIDIARY OF AMGEN INC (2024)View source (document specificity unverified) ↗
Toxics release filing — facility IMMUNEX RHODE ISLAND CORP A SUBSIDIARY OF AMGEN INC
EPA · Release Report Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed through PublicTrace entity resolution; verify the named party.
Federal lobbying
Showing 5 of 46
-
Lobbying — 4th Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $3,550,000 LDA · Lobbying Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Lobbying — 3rd Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $3,550,000 LDA · Lobbying Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Lobbying — 2nd Quarter - Amendment (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $2,580,000 LDA · Lobbying Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Lobbying — 2nd Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $2,580,000 LDA · Lobbying Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
-
Lobbying — 1st Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $3,610,000 LDA · Lobbying Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Attributed by a source-name match; verify the named party.View source (document specificity unverified) ↗
Securities disclosures
Showing 5 of 178
-
Registration SEC · Registration Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Linked by SEC CIK 0000318154.Source link unavailable
-
3 filingSEC company filings listing (not a specific filing) ↗
Form 3 - Initial statement of beneficial ownership of securities
SEC · Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Linked by SEC CIK 0000318154. -
4 filingSEC company filings listing (not a specific filing) ↗
Form 4 - Statement of changes in beneficial ownership of securities
SEC · Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Linked by SEC CIK 0000318154. -
4 filingSEC company filings listing (not a specific filing) ↗
Form 4 - Statement of changes in beneficial ownership of securities
SEC · Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Linked by SEC CIK 0000318154. -
144 filingSEC company filings listing (not a specific filing) ↗
Form 144 - Report of proposed sale of securities
SEC · Filing Company role: Unknown / not established · The entity match does not establish the company's role in this record. Why linked: Linked by SEC CIK 0000318154.
These records are currently attributed to Amgen through PublicTrace’s entity-resolution process. Verify the named party and original source before relying on a match. An absent category is not proof that no relevant record exists.
372 additional records · Complete history adds every source group, date/source filters, exports, saved monitoring, and API access.